ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

76 hedge funds and large institutions have $115M invested in Zynerba Pharmaceuticals, Inc in 2019 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+15
Holders Change %
+24.59%
% of All Funds
1.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
35
Increased
22
Reduced
7
Closed
17
Calls
$12.1M
Puts
$10.5M
Net Calls
+$1.6M
Net Calls Change
+$2.53M
Name Holding Trade Value Shares
Change
Shares
Change %
PP
76
PDT Partners
New York
-$476K -87,800 Closed
EGM
77
Engineers Gate Manager
New York
-$294K -54,321 Closed
Squarepoint
78
Squarepoint
New York
-$133K -24,453 Closed
SIM
79
Spark Investment Management
New York
-$130K -24,100 Closed
VF
80
Virtu Financial
New York
-$121K -22,384 Closed
ARTA
81
A.R.T. Advisors
New York
-$100K -18,388 Closed
Goldman Sachs
82
Goldman Sachs
New York
-$57K -10,495 Closed
Simplex Trading
83
Simplex Trading
Illinois
-$10K -1,989 Closed
OC
84
Oakworth Capital
Alabama
-$11K -1,965 Closed
PFO
85
Pathstone Family Office
New Jersey
-$5K -1,000 Closed
SWM
86
SeaCrest Wealth Management
New York
-$3K -510 Closed
FIA
87
FNY Investment Advisers
New York
-$2K -500 Closed
FANJ
88
Financial Architects (New Jersey)
New Jersey
-$2K -400 Closed
AIC
89
Ameritas Investment Company
Nebraska
-$2K -309 Closed
NWM
90
Northwest Wealth Management
Iowa
-$1K -200 Closed
WEC
91
Winslow Evans & Crocker
Massachusetts
-$2K -50 Closed